What is prognosis of Alzheimer?

['Ndai laika man hpe madat u']

Alzheimer ana hpe gara hku sawk sagawn chye ai kun?

Alzheimer ana gaw, n chye tsi ai, grau sawng wa ai ana re majaw, ana byin ai hpang hta ana n mai byin ai.

Masha langai hte langai hta ana byin ai lam shai ai raitim, aten na wa ai hte grau sawng wa ai majaw, chye chyang ai atsam hte hkum hkrang atsam yawm wa ai.

Ana byin wa ai hte maren, masha ni gaw matsing n lu mat ai, ga hte matut mahkai yak ai, myit n gring ai, myit masa hte akyang lailen galai shai ai lam ni byin chye ai.

Hpang jahtum hta, shanhte gaw tinang hkum tinang n lu lanu lahku mat nna aten tup karum shingtau lam ra wa chye ai.

Ana jep mu ai hpang, asak hkrung na matu lapran shaning gaw 8-10 daram rai tim, asak, hkum hkrang hkamja lam hte kaga lam ni a majaw grai shai chye ai.

Dai ana hpe tsi lajang ya lu ai lam n nga tim, tsi lajang ai lam ni gaw, ana a kumla ni hpe sharai ya lu nna, asak hkrung lam hpe grau kaja hkra galaw ya lu ai.

['Laika dum ni']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Kaldjian LC: Survival versus prognosis in Alzheimer disease. Ann Intern Med. 2004, 141 (7): 575; author reply 575.

Mayeux R, Stern Y, Sano M: Heterogeneity and prognosis in dementia of the Alzheimer type. Bull Clin Neurosci. 1985, 50 (): 7-10.

DeKosky ST, Golde T: Cerebrospinal Biomarkers in Alzheimer Disease-Potential Roles as Markers of Prognosis and Neuroplasticity. JAMA Neurol. 2016, 73 (5): 508-10.

Yaffe K: Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results. JAMA. 2010, 304 (17): 1952-3.

Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.

Malpetti M, Joie R, Rabinovici GD: Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials. J Nucl Med. 2022, 63 (6): 830-832.

Schaeffer EL, Figueiro M, Gattaz WF: Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo). 2011, 66 Suppl 1 (): 45-54.

Bhagwat N, Pipitone J, Voineskos AN, Chakravarty MM: An artificial neural network model for clinical score prediction in Alzheimer disease using structural neuroimaging measures J Psychiatry Neurosci. 2019, 44 (4): 246-260.

Vermunt L, van Paasen AJL, Teunissen CE, Scheltens P, Visser PJ, Tijms BM: Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Neurology. 2019, 92 (23): e2699-e2705.

Raji MA, Brady SR: Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother. 2001, 35 (9): 1024-7.

['N hkap la ai lam: tsi mawan']

['Ndai website gaw hpaji jaw ai hte chye na matu sha galaw da ai.']

['Ndai laika buk hta lawm ai lam ni hpe hkamja lam hte seng nna, ana jep ai (sh) tsi ai lam hta n mai jai lang ai.']

['Ga san ni a mahtai hpe shapraw ya ai neural net gaw, ga shadawn, masha langai ngai hta ana langai ngai mu lu ai lam ni hpe madun ai shaloi, n hkrak ai.']

['Ndai website hta mu lu ai lam ni a majaw, tsi sarawun ni a hpaji jaw ga hpe galoi mung n madat ai sha, hpang hkrat ai lam n galaw u. Tsi hte seng nna, ra kadawn nga ai lam nga yang, 911 hpe shaga u. Ndai website hte dai hpe lang ai lam gaw, tsi sarawun hte machyi masha lapran hku hkau lam n nga ai. BioMedLib hte shi a bungli galaw masha ni, ndai website hta shang lawm ai ni kadai mung, ndai kaw lawm ai shiga hte seng nna, tsun mayu ai lam (sh) tsun ai hku nna, hpa ga sadi jaw ai lam n nga ai.']

['Hti na ahkang n nga ai: copyright']

['1998 ning Digital Millennium Copyright Act, 17 U.S.C. § 512 (the DMCA) gaw Internet kaw mara da ai lam ni gaw US copyright law npu na madu a ahkaw ahkang hpe tawt lai ai ngu kam ai copyright madu ni hpe ahkaw ahkang jaw da ai.']

['Anhte a website hte seng nna, (sh) anhte a magam bungli ni hte seng nna, mara shagun da ai lam ni gaw, na a copyright hpe tawt lai ai ngu nna nang kam ai nga yang, dai lam ni hpe dawm kau na matu (sh) dai ni hpe n mai lu hkra pat kau na matu, nang (sh) na a kasa gaw anhte hpe shana mai ai.']

['Dai shiga ni hpe laika hte ka nna email hte shagun ra ai (email address hpe "Contact" daw kaw mu lu na re).']

['Dai DMCA gaw, na a copyright tawt lai ai lam hpe shana ai hta lawu na lam ni lawm ra ai: (1) tawt lai ai ngu ai copyright lu ai bungli a lam; (2) tawt lai ai ngu ai lam hte seng ai lam hte dai hpe mu tam lu na matu anhte hpe karum ya ai lam; (3) na a matut mahkai lam, na a shara, phone number hte email hte seng ai lam ni; (4) nang mara shagun ai lam gaw copyright madu, shi a agent (sh) tara upadi hte n seng ai ngu ai hpe nang kam ai lam.']

['(5) N teng n man ai sakse hkam ai lam hte seng nna, nang masat da ai hte maren, shana ai lam hta lawm ai shiga ni gaw teng man ai hte, nang tawt lai ai ngu ai copyright hpe hkan sa na ahkang nga ai lam.']

['hte (6) copyright madu a mying hte galaw na ahkang lu ai wa a hkum hkrang (sh) electronic signature.']

['Lahta na lam ni hpe n ka bang ai rai yang, nang shagun ai laika hpe hpang hkrat ai hte n mai htang ai.']

['Matut Mahkai U']

['Gara hku mung san mayu yang email hte shana ya rit.']

What is prognosis of alzheimer?

The prognosis of Alzheimer's disease is generally poor, as it is a progressive and degenerative condition with no known cure.

The rate of progression varies from person to person, but the disease typically worsens over time, leading to a decline in cognitive and physical abilities.

As the disease progresses, individuals may experience memory loss, difficulty with language and communication, disorientation, and changes in mood and behavior.

Eventually, they may become unable to care for themselves and require full-time assistance.

The average life expectancy after diagnosis is around 8-10 years, but this can vary widely depending on the individual's age, overall health, and other factors.

While there is no cure, treatments and therapies can help manage symptoms and improve quality of life for those with Alzheimer's disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.